Micrima is developing radiowave radar technology for medical imaging applications, primarily for breast cancer. Micrima’s patented techniques will enable breast screening to become safer, more convenient and accessible, and more economically viable in an increased number of countries. The technology is non-invasive, non-ionising and inexpensive. It has benefited from extensive validation in the laboratory and is now undergoing clinical trials.